The options that apply, with the guideline and the evidence under each

Every option carries the recommendation it rests on and the study behind it: what it changes in numbers, the population that was studied, and the sentence that says where this patient differs. Her own record stands beside the option it touches, an earlier reaction as much as a value that rules a drug out.

Step 1

AKAnna Keller, 47 · Hypertension, prediabetes, LDL 162 mg/dl · 14 documents, read 16 September 2026

Given her history and today's findings, what should I consider next?

Answered on 16 September 2026

Finished thinking

Practice guidelineEuropean Society of Cardiology

ESC 2021: in apparently healthy people under 50, SCORE2 estimates the 10-year risk; risk modifiers such as a family history of premature cardiovascular disease, lipoprotein(a) and coronary artery calcium can move a patient across a treatment threshold. At low-to-moderate risk, lipid-lowering treatment should be considered when LDL cholesterol stays at or above 100 mg/dl after lifestyle intervention. Eur Heart J

European Society of Cardiology

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

Visseren FLJ, Mach F, Smulders YM, et al. European Heart Journal. 2021;42:3227-3337. doi:10.1093/eurheartj/ehab484.

Her SCORE2 (moderate-risk region, 47 years, non-smoker now, systolic 142, non-HDL 186 mg/dl) is about 3 %, low to moderate for her age. Check-up 12.05.2026 Lab 08.05.2026 Eur Heart J Three modifiers push upward: her father's infarction at 58, an LDL of 162 mg/dl and prediabetes with steatosis. Intake 20.09.2023 Lab 08.05.2026 Ultrasound 12.05.2026

Lipids: statin rechallenge with atorvastatin 10 mg or rosuvastatin 5 mg, LDL target below 100 mg/dl, lipids, ALT and CK after eight weeks; lipoprotein(a) once with the next draw. Eur Heart J + 2
Blood pressure: home mean 136/86 is above the ESC 2024 target of 120 to 129 systolic; increase ramipril to 10 mg, potassium and creatinine after two weeks, home log again in four weeks. BP log 15.09.2026 Eur Heart J
Prediabetes and liver: structured lifestyle programme (the Diabetes Prevention Program reduced diabetes incidence by 58 %), HbA1c in three to six months, FIB-4 from the May values. NEJM J Hepatol
Optional risk refinement: a coronary calcium scan if she or you want more certainty before committing to long-term treatment. Eur Heart J

Today's draft note already lists the statin start, the ramipril increase and the booster; the FIB-4 and the lifestyle programme are not yet in it. Visit 16.09.2026

See the full response

Step 2

AKAnna Keller, 47 · Hypertension, prediabetes, LDL 162 mg/dl · 14 documents, read 16 September 2026

What does the current guideline recommend as her blood pressure target?

Answered on 16 September 2026

Finished thinking

Practice guidelineEuropean Society of Cardiology

The 2024 ESC guideline recommends a systolic target of 120 to 129 mmHg for most adults on treatment, provided it is tolerated, and home blood pressure monitoring to guide treatment; home readings run about 5 mmHg below office values. Eur Heart J

European Society of Cardiology

2024 ESC Guidelines for the management of elevated blood pressure and hypertension.

McEvoy JW, McCarthy CP, Bruno RM, et al. European Heart Journal. 2024;45:3912-4018. doi:10.1093/eurheartj/ehae178.

For her: home mean 136/86 mmHg and office 142/90 are above target on ramipril 5 mg. BP log 15.09.2026 Visit 16.09.2026 The guideline's first step is to optimise the existing drug or move to a combination; with eGFR 92 and normal potassium, ramipril 10 mg is the straightforward step, with a combination (ramipril plus amlodipine) if the home mean stays above 135/85 after four weeks. Lab 08.05.2026 Eur Heart J

Home measurement: seated after five minutes of rest, two readings in the morning and two in the evening for seven days, discarding the first day. Her log follows that scheme. BP log 15.09.2026 Eur Heart J

See the full response